Blood Advances | 2024
Health-related quality of life with gilteritinib versus placebo post-transplant for FLT3-ITD+ acute myeloid leukemia.
Hamilton BK, Pandya BJ, Ivanescu C, Elsouda D, Hamadani M, Chen Y-B, Levis MJ, Ueda Oshima M, Litzow MR, Soiffer RJ, Ustun C, Perl AE, Singh AK, Geller N, Hasabou N, Rosales M, Cella D, Corredoira L, Pestana C, Horowitz MH, Logan B
PubMed
PMID: 39167766
Abstract
Related Articles
CIBMTR Study #: BMT1506